Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Impact of Image-Derived Instrumentation on Total Knee Arthroplasty Revision Rates: An Analysis of 83,823 Procedures from the Australian Orthopaedic Association National Joint Replacement Registry.

McAuliffe MJ, Beer BR, Hatch JJ, Crawford RW, Cuthbert AR, Donnelly WJ.

J Bone Joint Surg Am. 2019 Apr 3;101(7):580-588. doi: 10.2106/JBJS.18.00326.

PMID:
30946191
2.

Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro.

Saborowski A, Wolff K, Spielberg S, Beer B, Hartleben B, Erlangga Z, Becker D, Dow LE, Marhenke S, Woller N, Unger K, Schirmacher P, Manns MP, Marquardt JU, Vogel A, Saborowski M.

Hepatol Commun. 2019 Feb 5;3(3):423-436. doi: 10.1002/hep4.1312. eCollection 2019 Mar.

3.

Microbial production of high value molecules using rayon waste material as carbon-source.

Vecchiato S, Skopek L, Russmayer H, Steiger MG, Aldrian A, Beer B, Herrero Acero E, Guebitz GM.

N Biotechnol. 2019 Jul 25;51:8-13. doi: 10.1016/j.nbt.2019.01.010. Epub 2019 Feb 1.

PMID:
30716417
4.

Substrate scope of a dehydrogenase from Sphingomonas species A1 and its potential application in the synthesis of rare sugars and sugar derivatives.

Beer B, Pick A, Döring M, Lommes P, Sieber V.

Microb Biotechnol. 2018 Jul;11(4):747-758. doi: 10.1111/1751-7915.13272. Epub 2018 Apr 26.

5.

Thermostabilization of the uronate dehydrogenase from Agrobacterium tumefaciens by semi-rational design.

Roth T, Beer B, Pick A, Sieber V.

AMB Express. 2017 Dec;7(1):103. doi: 10.1186/s13568-017-0405-2. Epub 2017 May 23.

6.

A Dual-Enzyme Hydrogen Peroxide Generation Machinery in Hydrogels Supports Antimicrobial Wound Treatment.

Huber D, Tegl G, Mensah A, Beer B, Baumann M, Borth N, Sygmund C, Ludwig R, Guebitz GM.

ACS Appl Mater Interfaces. 2017 May 10;9(18):15307-15316. doi: 10.1021/acsami.7b03296. Epub 2017 Apr 25.

PMID:
28429928
7.

Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?

Oberguggenberger A, Meraner V, Sztankay M, Beer B, Weigel G, Oberacher H, Kemmler G, Czech T, Holzner B, Wildt L, Sperner-Unterweger B, Daniaux M, Hubalek M.

BMC Cancer. 2017 Mar 28;17(1):226. doi: 10.1186/s12885-017-3208-6.

8.

In vitro metabolic engineering for the production of α-ketoglutarate.

Beer B, Pick A, Sieber V.

Metab Eng. 2017 Mar;40:5-13. doi: 10.1016/j.ymben.2017.02.011. Epub 2017 Feb 22.

9.

Identification and characterization of two new 5-keto-4-deoxy-D-Glucarate Dehydratases/Decarboxylases.

Pick A, Beer B, Hemmi R, Momma R, Schmid J, Miyamoto K, Sieber V.

BMC Biotechnol. 2016 Nov 17;16(1):80.

10.

Cellobiose dehydrogenase and chitosan-based lysozyme responsive materials for antimicrobial wound treatment.

Öhlknecht C, Tegl G, Beer B, Sygmund C, Ludwig R, Guebitz GM.

Biotechnol Bioeng. 2017 Feb;114(2):416-422. doi: 10.1002/bit.26070. Epub 2016 Sep 21.

PMID:
27500401
11.

Antimicrobial Cellobiose Dehydrogenase-Chitosan Particles.

Tegl G, Thallinger B, Beer B, Sygmund C, Ludwig R, Rollett A, Nyanhongo GS, Guebitz GM.

ACS Appl Mater Interfaces. 2016 Jan 13;8(1):967-73. doi: 10.1021/acsami.5b10801. Epub 2015 Dec 28.

PMID:
26672396
12.

A water-forming NADH oxidase from Lactobacillus pentosus suitable for the regeneration of synthetic biomimetic cofactors.

Nowak C, Beer B, Pick A, Roth T, Lommes P, Sieber V.

Front Microbiol. 2015 Sep 16;6:957. doi: 10.3389/fmicb.2015.00957. eCollection 2015.

13.

CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine.

Klieber M, Oberacher H, Hofstaetter S, Beer B, Neururer M, Amann A, Alber H, Modak A.

J Pharmacol Exp Ther. 2015 Sep;354(3):426-30. doi: 10.1124/jpet.115.225680. Epub 2015 Jul 9.

PMID:
26159874
14.

Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer.

Hüfner K, Oberguggenberger A, Kohl C, Geisler S, Gamper E, Meraner V, Egeter J, Hubalek M, Beer B, Fuchs D, Sperner-Unterweger B.

Psychoneuroendocrinology. 2015 Oct;60:28-38. doi: 10.1016/j.psyneuen.2015.06.001. Epub 2015 Jun 8.

PMID:
26112459
15.

Causal inferences about others' behavior among the Wampar, Papua New Guinea - and why they are hard to elicit.

Beer B, Bender A.

Front Psychol. 2015 Mar 10;6:128. doi: 10.3389/fpsyg.2015.00128. eCollection 2015.

16.

Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients.

Oberguggenberger A, Goebel G, Beer B, Oberacher H, Meraner V, Sztankay M, Sperner-Unterweger B, Zeimet AG, Marth C, Hubalek M, Holzner B.

Breast J. 2014 Sep-Oct;20(5):555-7. doi: 10.1111/tbj.12323. Epub 2014 Jul 8. No abstract available.

PMID:
25040193
17.

Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women.

Alekel DL, Genschel U, Koehler KJ, Hofmann H, Van Loan MD, Beer BS, Hanson LN, Peterson CT, Kurzer MS.

Menopause. 2015 Feb;22(2):185-97. doi: 10.1097/GME.0000000000000280.

18.

A comprehensive analysis of the geranylgeranylglyceryl phosphate synthase enzyme family identifies novel members and reveals mechanisms of substrate specificity and quaternary structure organization.

Peterhoff D, Beer B, Rajendran C, Kumpula EP, Kapetaniou E, Guldan H, Wierenga RK, Sterner R, Babinger P.

Mol Microbiol. 2014 May;92(4):885-99. doi: 10.1111/mmi.12596. Epub 2014 Apr 16.

19.

Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.

Hubalek M, Oberguggenberger A, Beer B, Meraner V, Sztankay M, Oberacher H, Schubert B, Wildt L, Seeber B, Giesinger J, Kemmler G, Holzner B, Sperner-Unterweger B.

Clin Breast Cancer. 2014 Aug;14(4):291-6. doi: 10.1016/j.clbc.2013.12.008. Epub 2013 Dec 27.

PMID:
24468298
20.

Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.

Beer B, Erb R, Pavlic M, Ulmer H, Giacomuzzi S, Riemer Y, Oberacher H.

PLoS One. 2013 Sep 25;8(9):e75359. doi: 10.1371/journal.pone.0075359. eCollection 2013.

21.

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.

Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M.

BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474.

22.

A novel amplification strategy for genotyping with liquid chromatography-electrospray ionization mass spectrometry.

Beer B, Krjutškov K, Erb R, Viltrop T, Oberacher H.

Analyst. 2012 Nov 21;137(22):5325-33. doi: 10.1039/c2an35440c.

PMID:
23034565
23.

CYP2D6 genotyping in breast cancer patients by liquid chromatography-electrospray ionization mass spectrometry.

Beer B, Plattner S, Hubalek M, Oberguggenberger A, Sztankay M, Meraner V, Achleitner R, Oberacher H.

Horm Mol Biol Clin Investig. 2011 Oct 1;6(3):247-53. doi: 10.1515/HMBCI.2011.015.

PMID:
25961262
24.

Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).

Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, Giesinger J, Kemmler G, Egle D, Gamper EM, Sperner-Unterweger B, Holzner B.

Breast Cancer Res Treat. 2011 Jul;128(2):553-61. doi: 10.1007/s10549-011-1378-5. Epub 2011 Feb 11.

PMID:
21311968
25.

Adhesion of preosteoblasts and fibroblasts onto poly(pentafluorostyrene)-based glycopolymeric films and their biocompatibility.

Babiuch K, Becer CR, Gottschaldt M, Delaney JT, Weisser J, Beer B, Wyrwa R, Schnabelrauch M, Schubert US.

Macromol Biosci. 2011 Apr 8;11(4):535-48. doi: 10.1002/mabi.201000374. Epub 2011 Jan 21.

PMID:
21259436
26.

CYP2D6 genotyping by liquid chromatography-electrospray ionization mass spectrometry.

Beer B, Erb R, Pitterl F, Niederstätter H, Maroñas O, Gesteira A, Carracedo A, Piatkov I, Oberacher H.

Anal Bioanal Chem. 2011 Jun;400(8):2361-70. doi: 10.1007/s00216-010-4597-4. Epub 2011 Jan 12.

PMID:
21225252
27.

3D versus 2D cell culture implications for electron microscopy.

Hess MW, Pfaller K, Ebner HL, Beer B, Hekl D, Seppi T.

Methods Cell Biol. 2010;96:649-70. doi: 10.1016/S0091-679X(10)96027-5.

PMID:
20869542
28.

Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.

Beer B, Schubert B, Oberguggenberger A, Meraner V, Hubalek M, Oberacher H.

Anal Bioanal Chem. 2010 Oct;398(4):1791-800. doi: 10.1007/s00216-010-4075-z. Epub 2010 Aug 22.

PMID:
20730580
29.

[Impact of slow-release oral morphine on drug abusing habits in Austria].

Beer B, Rabl W, Libiseller K, Giacomuzzi S, Riemer Y, Pavlic M.

Neuropsychiatr. 2010;24(2):108-17. German.

PMID:
20605006
30.

A fatal intoxication case involving topiramate.

Beer B, Libiseller K, Oberacher H, Pavlic M.

Forensic Sci Int. 2010 Oct 10;202(1-3):e9-11. doi: 10.1016/j.forsciint.2010.04.035. Epub 2010 May 21.

PMID:
20494535
31.

A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder.

Czobor P, Skolnick P, Beer B, Lippa A.

CNS Neurosci Ther. 2010 Apr;16(2):63-75. doi: 10.1111/j.1755-5949.2009.00109.x. Epub 2009 Dec 22.

32.

Challenging small human hepatocytes with opiates: further characterization of a novel prototype bioartificial liver.

Wurm M, Woess C, Libiseller K, Beer B, Pavlic M.

Tissue Eng Part A. 2010 Mar;16(3):807-13. doi: 10.1089/ten.TEA.2009.0420.

PMID:
19778170
33.

Animal tests of anxiety.

File SE, Lippa AS, Beer B, Lippa MT.

Curr Protoc Neurosci. 2004 May;Chapter 8:Unit 8.3. doi: 10.1002/0471142301.ns0803s26.

PMID:
18428606
34.

Sacral nerve stimulation in patients after rectal resection--preliminary report.

Holzer B, Rosen HR, Zaglmaier W, Klug R, Beer B, Novi G, Schiessel R.

J Gastrointest Surg. 2008 May;12(5):921-5. doi: 10.1007/s11605-008-0485-z. Epub 2008 Feb 16.

PMID:
18278538
35.

IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium.

Lechner J, Malloth N, Seppi T, Beer B, Jennings P, Pfaller W.

Am J Physiol Cell Physiol. 2008 Jan;294(1):C153-60. Epub 2007 Nov 21.

36.

Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity.

Nevinny-Stickel M, Poljanc K, Forthuber BC, Heute D, Posch A, Lechner J, Beer B, Lukas P, Seppi T.

Strahlenther Onkol. 2007 Jul;183(7):385-91.

PMID:
17609872
37.

CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.

Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D, Venzon D, Nacsa J, Betts MR, Tsai WP, Heraud JM, Beer B, Blanset D, Chougnet C, Lowy I, Shearer GM, Franchini G.

Blood. 2006 Dec 1;108(12):3834-42. Epub 2006 Aug 8. Erratum in: Blood. 2009 Oct 1;114(14):3132.

38.

In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Beer BE, Doncel GF, Krebs FC, Shattock RJ, Fletcher PS, Buckheit RW Jr, Watson K, Dezzutti CS, Cummins JE, Bromley E, Richardson-Harman N, Pallansch LA, Lackman-Smith C, Osterling C, Mankowski M, Miller SR, Catalone BJ, Welsh PA, Howett MK, Wigdahl B, Turpin JA, Reichelderfer P.

Antimicrob Agents Chemother. 2006 Feb;50(2):713-23.

39.

Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with Simian immunodeficiency virus SIVsun or SIVlhoest.

Beer BE, Brown CR, Whitted S, Goldstein S, Goeken R, Plishka R, Buckler-White A, Hirsch VM.

J Virol. 2005 Nov;79(22):14044-56.

40.

The effect of otitis media in childhood on the development of middle ear admittance on reaching adulthood.

de Beer B, Snik A, Schilder AG, Graamans K, Zielhuis GA.

Arch Otolaryngol Head Neck Surg. 2005 Sep;131(9):777-81.

PMID:
16172353
41.

Natural course of tympanic membrane pathology related to otitis media and ventilation tubes between ages 8 and 18 years.

De Beer BA, Schilder AG, Zielhuis GA, Graamans K.

Otol Neurotol. 2005 Sep;26(5):1016-21.

PMID:
16151352
42.

Primate-to-human retroviral transmission in Asia.

Jones-Engel L, Engel GA, Schillaci MA, Rompis A, Putra A, Suaryana KG, Fuentes A, Beer B, Hicks S, White R, Wilson B, Allan JS.

Emerg Infect Dis. 2005 Jul;11(7):1028-35.

43.

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

Lippa A, Czobor P, Stark J, Beer B, Kostakis E, Gravielle M, Bandyopadhyay S, Russek SJ, Gibbs TT, Farb DH, Skolnick P.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7380-5. Epub 2005 May 3.

44.

Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques.

Mueller YM, Petrovas C, Bojczuk PM, Dimitriou ID, Beer B, Silvera P, Villinger F, Cairns JS, Gracely EJ, Lewis MG, Katsikis PD.

J Virol. 2005 Apr;79(8):4877-85.

45.

Ancient co-speciation of simian foamy viruses and primates.

Switzer WM, Salemi M, Shanmugam V, Gao F, Cong ME, Kuiken C, Bhullar V, Beer BE, Vallet D, Gautier-Hion A, Tooze Z, Villinger F, Holmes EC, Heneine W.

Nature. 2005 Mar 17;434(7031):376-80.

PMID:
15772660
46.

Animal tests of anxiety.

File SE, Lippa AS, Beer B, Lippa MT.

Curr Protoc Pharmacol. 2005 Jan 1;Chapter 5:Unit 5.38. doi: 10.1002/0471141755.ph0538s27.

PMID:
22294128
47.

DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile.

Beer B, Stark J, Krieter P, Czobor P, Beer G, Lippa A, Skolnick P.

J Clin Pharmacol. 2004 Dec;44(12):1360-7.

PMID:
15545306
48.

Further investigation of simian immunodeficiency virus Vif function in human cells.

Gaddis NC, Sheehy AM, Ahmad KM, Swanson CM, Bishop KN, Beer BE, Marx PA, Gao F, Bibollet-Ruche F, Hahn BH, Malim MH.

J Virol. 2004 Nov;78(21):12041-6.

49.

Hearing loss in young adults who had ventilation tube insertion in childhood.

de Beer BA, Schilder AG, Ingels K, Snik AF, Zielhuis GA, Graamans K.

Ann Otol Rhinol Laryngol. 2004 Jun;113(6):438-44.

PMID:
15224825
50.

Antiviral activity of hop constituents against a series of DNA and RNA viruses.

Buckwold VE, Wilson RJ, Nalca A, Beer BB, Voss TG, Turpin JA, Buckheit RW 3rd, Wei J, Wenzel-Mathers M, Walton EM, Smith RJ, Pallansch M, Ward P, Wells J, Chuvala L, Sloane S, Paulman R, Russell J, Hartman T, Ptak R.

Antiviral Res. 2004 Jan;61(1):57-62.

PMID:
14670594

Supplemental Content

Support Center